{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:21:20Z","timestamp":1793024480974,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1053\/j.ajkd.2023.12.014","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:49:32Z","timestamp":1707439772000},"page":"102-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["APOL1 Nephropathy Risk Variants Through the Life Course: A Review"],"prefix":"10.1053","volume":"84","author":[{"given":"Ai","family":"Itoku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5436-5863","authenticated-orcid":false,"given":"Scott","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Reidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Kaskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5993","key":"10.1053\/j.ajkd.2023.12.014_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.014_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ekir.2019.04.002","article-title":"APOL1 risk genotypes are associated with early kidney damage in children in Sub-Saharan Africa","volume":"4","author":"Ekulu","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.semnephrol.2015.04.008","article-title":"APOL1 kidney disease risk variants: an evolving landscape","volume":"35","author":"Dummer","year":"2015","journal-title":"Semin Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.014_bib6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and collapsing glomerulopathy associated with COVID-19 and APOL 1 high-risk genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib7","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/cts.2020.492","article-title":"Charting the life course: emerging opportunities to advance scientific approaches using life course research","volume":"5","author":"Hanson","year":"2020","journal-title":"J\u00a0Clin Transl Sci"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.kint.2018.03.017","article-title":"Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions","volume":"94","author":"Langefeld","year":"2018","journal-title":"Kidney Int"},{"issue":"5733","key":"10.1053\/j.ajkd.2023.12.014_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.014_bib10","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/febs.13706","article-title":"Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1","volume":"283","author":"Sharma","year":"2016","journal-title":"FEBS J"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051546","article-title":"APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib12","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"20","key":"10.1053\/j.ajkd.2023.12.014_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136329","article-title":"The key role of NLRP3 and STING in APOL1-associated podocytopathy","volume":"131","author":"Wu","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib14","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.immuni.2021.10.004","article-title":"APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis","volume":"54","author":"Wu","year":"2021","journal-title":"Immunity"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.014_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.semnephrol.2017.07.007","article-title":"The cell biology of APOL1","volume":"37","author":"O\u2019Toole","year":"2017","journal-title":"Semin Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib16","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1681\/ASN.2015111220","article-title":"APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease","volume":"27","author":"Bruggeman","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.014_bib17","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.048952","article-title":"Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease","volume":"14","author":"McCarthy","year":"2021","journal-title":"Dis Model Mech"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.014_bib18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157432","article-title":"JAK inhibitor blocks COVID-19 cytokine-induced JAK\/STAT\/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids","volume":"7","author":"Nystrom","year":"2022","journal-title":"JCI Insight"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.014_bib20","first-page":"983","article-title":"APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts","volume":"32","author":"Ng","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajhg.2018.08.002","article-title":"Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry","volume":"103","author":"Reidy","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib22","first-page":"2051","article-title":"An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts","volume":"32","author":"Robertson","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.014_bib23","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1053\/j.ajkd.2020.10.020","article-title":"Joint associations of maternal-fetal APOL1 genotypes and maternal country of origin with preeclampsia risk","volume":"77","author":"Hong","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1006\/geno.2001.6534","article-title":"The human apolipoprotein L gene cluster: identification, classification, and sites of distribution","volume":"74","author":"Page","year":"2001","journal-title":"Genomics"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.014_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000529850","article-title":"Fetal high-risk APOL1 genotype increases risk for small for gestational age in term infants affected by preeclampsia","volume":"120","author":"Azhibekov","year":"2023","journal-title":"Neonatology"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.014_bib26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1681\/ASN.2013111242","article-title":"Clinical features and histology of apolipoprotein L1-associated nephropathy in the FSGS clinical trial","volume":"26","author":"Kopp","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib27","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100563","article-title":"APOL1 genotype, proteinuria, and the risk of kidney failure: a secondary analysis of the AASK (African American Study of Kidney Disease and Hypertension) and CRIC (Chronic Renal Insufficiency Cohort) Studies","volume":"4","author":"Nguyen","year":"2022","journal-title":"Kidney Med"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.014_bib29","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2023.12.014_bib30","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.nephro.2019.02.005","article-title":"APOL1 risk genotype in Europe: data in patients with focal segmental glomerulosclerosis and after renal transplantation","volume":"15","author":"Servais","year":"2019","journal-title":"Nephrol Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.014_bib31","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1681\/ASN.2017060658","article-title":"APOL1 genotype and renal function of Black living donors","volume":"29","author":"Doshi","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ekir.2019.11.022","article-title":"APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): design and rationale","volume":"5","author":"Freedman","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"41","key":"10.1053\/j.ajkd.2023.12.014_bib33","doi-asserted-by":"crossref","first-page":"25576","DOI":"10.1074\/jbc.272.41.25576","article-title":"Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L","volume":"272","author":"Duchateau","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"3-4","key":"10.1053\/j.ajkd.2023.12.014_bib34","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/hmg\/ddab022","article-title":"APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis","volume":"30","author":"Ge","year":"2021","journal-title":"Hum Mol Genet"},{"key":"10.1053\/j.ajkd.2023.12.014_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fped.2016.00122","article-title":"Renal and cardiovascular morbidities associated with APOL1 status among African-American and non-African-American children with focal segmental glomerulosclerosis","volume":"4","author":"Woroniecki","year":"2016","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.014_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamainternmed.2021.8538","article-title":"APOL1 risk variants, acute kidney injury, and death in participants with African ancestry hospitalized with COVID-19 from the Million Veteran Program","volume":"182","author":"Hung","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.118.036589","article-title":"Association of APOL1 risk alleles with cardiovascular disease in Blacks in the Million Veteran Program","volume":"140","author":"Bick","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1053\/j.ajkd.2023.12.014_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ Res"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1053\/j.ajkd.2023.12.014_bib40","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1161\/ATVBAHA.120.315788","article-title":"APOL1 genetic variants are associated with increased risk of coronary atherosclerotic plaque rupture in the Black population","volume":"41","author":"Cornelissen","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ekir.2017.08.007","article-title":"APOL1 risk variants independently associated with early cardiovascular disease death","volume":"3","author":"Hughson","year":"2018","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.014_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamacardio.2018.1827","article-title":"Association of APOL1 with heart failure with preserved ejection fraction in postmenopausal African American women","volume":"3","author":"Franceschini","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib43","article-title":"Association between APOL1 genotypes and risk of cardiovascular disease in MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"6","author":"Chen","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1053\/j.ajkd.2023.12.014_bib44","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","author":"Grams","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2023.12.014_bib45","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/ATVBAHA.117.309384","article-title":"APOL1 risk variants and cardiovascular disease: results from the AASK (African American Study of Kidney Disease and Hypertension)","volume":"37","author":"Chen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.014_bib46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ekir.2017.03.008","article-title":"APOL1 renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention Trial","volume":"2","author":"Freedman","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.kint.2017.08.019","article-title":"APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults","volume":"93","author":"Guti\u00e9rrez","year":"2018","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000453458","article-title":"Apolipoprotein L1 genetic variants are associated with chronic kidney disease but not with cardiovascular disease in a population referred for cardiac catheterization","volume":"7","author":"Wang","year":"2017","journal-title":"Cardiorenal Med"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ekir.2020.11.006","article-title":"APOL1 risk variants and subclinical cardiovascular disease in incident hemodialysis patients","volume":"6","author":"Chen","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.014_bib50","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1681\/ASN.2019030240","article-title":"APOL1 kidney risk variants and cardiovascular disease: an individual participant data meta-analysis","volume":"30","author":"Grams","year":"2019","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib51","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/art.38220","article-title":"End-stage renal disease in African Americans with lupus nephritis is associated with APOL1","volume":"66","author":"Freedman","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000460","article-title":"Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study","volume":"8","author":"Blazer","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"8","key":"10.1053\/j.ajkd.2023.12.014_bib53","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3899\/jrheum.190684","article-title":"Effect of a single apolipoprotein L1 gene nephropathy variant on the risk of advanced lupus nephritis in Brazilians","volume":"47","author":"Vajgel","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2141.2011.08832.x","article-title":"MYH9 and APOL1 are both associated with sickle cell disease nephropathy","volume":"155","author":"Ashley-Koch","year":"2011","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.014_bib55","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3324\/haematol.2015.124875","article-title":"Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy","volume":"100","author":"Saraf","year":"2015","journal-title":"Haematologica"},{"issue":"10","key":"10.1053\/j.ajkd.2023.12.014_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164364","article-title":"Genetic modifiers of white blood cell count, albuminuria and glomerular filtration rate in children with sickle cell anemia","volume":"11","author":"Schaefer","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/bjh.14842","article-title":"Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target","volume":"179","author":"Kormann","year":"2017","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000276","article-title":"Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection","volume":"5","author":"Samanovic","year":"2009","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection","volume":"88","author":"Taylor Harry","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib60","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-021-00647-3","article-title":"APOL1 variants contribute to racial disparity in sepsis","volume":"21","author":"Bird","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib61","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2215\/CJN.04490419","article-title":"APOL1 nephropathy risk alleles and risk of sepsis in Blacks","volume":"14","author":"Chaudhary","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib62","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in Black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib63","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM198403153101101","article-title":"Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome","volume":"310","author":"Rao","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib64","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1681\/ASN.2011060562","article-title":"APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease","volume":"23","author":"Fine","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42003-021-01812-z","article-title":"APOL1 variant alleles associate with reduced risk for opportunistic infections in HIV infection","volume":"4","author":"An","year":"2021","journal-title":"Commun Biol"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib66","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2215\/CJN.01070121","article-title":"APOL1 risk variants and acute kidney injury in Black Americans with COVID-19","volume":"16","author":"Larsen","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.12.014_bib67","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.kint.2021.07.015","article-title":"A\u00a0multi-center retrospective cohort study defines the spectrum of kidney pathology in coronavirus 2019 disease (COVID-19)","volume":"100","author":"May","year":"2021","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib68","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1681\/ASN.2021070931","article-title":"Longitudinal outcomes of COVID-19-associated collapsing glomerulopathy and other podocytopathies","volume":"32","author":"Kudose","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.12.014_bib69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.12.010","article-title":"SARS-CoV-2 infects the human kidney and drives fibrosis in kidney organoids","volume":"29","author":"Jansen","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1053\/j.ajkd.2023.12.014_bib70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2215\/CJN.11921019","article-title":"Association of APOL1 risk genotype and air pollution for kidney disease","volume":"15","author":"Paranjpe","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.12.014_bib71","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ki.2012.263","article-title":"Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans","volume":"83","author":"Lipkowitz","year":"2013","journal-title":"Kidney Int"},{"issue":"5 suppl 1","key":"10.1053\/j.ajkd.2023.12.014_bib72","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1053\/j.ajkd.2018.06.020","article-title":"APOL1-associated nephropathy: a key contributor to racial disparities in CKD","volume":"72","author":"Freedman","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2023.12.014_bib73","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2023.12.014_bib74","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126124","article-title":"Antisense oligonucleotide treatment ameliorates IFN-\u03b3-induced proteinuria in APOL1-transgenic mice","volume":"4","author":"Aghajan","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1053\/j.ajkd.2023.12.014_bib75","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.pcl.2010.07.015","article-title":"Implementing a specialty electronic medical record to document a life-course developmental model and facilitate clinical interventions in spina bifida clinics","volume":"57","author":"Fairman","year":"2010","journal-title":"Pediatr Clin North Am"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638624005973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638624005973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T12:34:19Z","timestamp":1718800459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638624005973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0272638624005973"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.014","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1 Nephropathy Risk Variants Through the Life Course: A Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}